Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XIN
2476
DELISTED
Xinyuan Real Estate
XIN
| $1.33M | ﹤0.01% |
32,888
+2,538
| +8% | +$106K |
|
2477
Consumer Portfolio Services
CPSS
$208M
| $1.33M | ﹤0.01% |
370,908
+17,999
| +5% | +$65K |
|
2478
The Joint Corp
JYNT
$120M
| $1.33M | ﹤0.01% |
71,471
-36,900
| -34% | -$683K |
|
2479
American Coastal Insurance
ACIC
$467M
| $1.33M | ﹤0.01% |
94,900
-33,853
| -26% | -$436K |
|
|
ADAP
2480
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.33M | ﹤0.01% |
878,759
+381,659
| +77% | +$892K |
|
2481
Four Corners Property Trust
FCPT
$2.77B
| $1.33M | ﹤0.01% |
46,900
+21,600
| +85% | +$602K |
|
2482
Educational Development Corp
EDUC
$11.8M
| $1.32M | ﹤0.01% |
214,024
+11,600
| +6% | +$74K |
|
2483
Vanguard Long-Term Bond ETF
BLV
$5.69B
| $1.31M | ﹤0.01% |
12,800
-3,500
| -21% | -$352K |
|
|
AHG
2484
Akso Health Group
AHG
$1.07B
| $1.31M | ﹤0.01% |
286,122
+75,029
| +36% | +$470K |
|
2485
Farmers & Merchants Bancorp
FMAO
$489M
| $1.31M | ﹤0.01% |
50,400
+14,200
| +39% | +$378K |
|
|
RIBT
2486
DELISTED
RiceBran Technologies
RIBT
| $1.3M | ﹤0.01% |
51,018
-9,990
| -16% | -$273K |
|
2487
Red Robin
RRGB
$190M
| $1.3M | ﹤0.01% |
39,066
-54,800
| -58% | -$1.8M |
|
|
ARAV
2488
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.29M | ﹤0.01% |
172,659
+24,394
| +16% | +$152K |
|
|
AUTO
2489
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $1.29M | ﹤0.01% |
417,390
+9,800
| +2% | +$28.6K |
|
|
GDP
2490
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $1.29M | ﹤0.01% |
121,400
+6,900
| +6% | +$76K |
|
2491
First US Bancshares
FUSB
$90.8M
| $1.28M | ﹤0.01% |
143,564
+2,900
| +2% | +$26.3K |
|
|
NBSE
2492
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.28M | ﹤0.01% |
12,876
+2,185
| +20% | +$216K |
|
2493
Arcus Biosciences
RCUS
$3.76B
| $1.28M | ﹤0.01% |
140,838
+106,238
| +307% | +$854K |
|
2494
Cedar Fair
FUN
$1.7B
| $1.28M | ﹤0.01% |
21,941
-50,209
| -70% | -$2.65M |
|
2495
NI Holdings
NODK
$314M
| $1.28M | ﹤0.01% |
74,601
+4,364
| +6% | +$73.9K |
|
2496
Flanigan's Enterprises
BDL
$87M
| $1.28M | ﹤0.01% |
55,900
+1,100
| +2% | +$24.3K |
|
|
GURE
2497
Gulf Resources
GURE
$4.71M
| $1.28M | ﹤0.01% |
36,603
+874
| +2% | +$36.1K |
|
2498
Aptevo Therapeutics
APVO
$4.54M
| – | – |
0
| – | – |
|
2499
Knowles
KN
$3.28B
| $1.27M | ﹤0.01% |
62,674
-513,800
| -89% | -$10.1M |
|
|
SACH
2500
Sachem Capital Corp
SACH
$38.1M
| $1.27M | ﹤0.01% |
269,500
+51,300
| +24% | +$253K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.